Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,481.60 +93.99 0.61%
S&P 500 1,678.41 +9.25 0.55%
Nasdaq 3,516.27 +14.15 0.40%
Ticker Volume Price Price Delta
STOXX 50 2,827.99 +6.34 0.22%
FTSE 100 6,841.45 +37.58 0.55%
DAX 8,527.39 +55.19 0.65%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: Xetra
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Stada Arzneimittel AG

+ Add to Watchlist

SAZ:GR

34.010 EUR 0.165 0.48%

As of 10:58:51 ET on 05/22/2013.

Company Profile for Stada Arzneimittel AG (SAZ)

Stada Arzneimittel AG manufactures pharmaceuticals. The Company produces generics (products whose patents have expired), brand-name products, and cancer therapy and other special pharmaceuticals. Stada avoids cost-intensive research on active ingredients and concentrates on multi-source products. The Company markets its products worldwide.

Contact Information

Stada Arzneimittel AG

Stadastrasse 2-18
Bad Vilbel, 61118
Germany
Phone: 49-6101-603-0
Fax: 49-6101-603-259

Key Executives for Stada Arzneimittel AG (SAZ)

Hartmut RetzlaffChairman-Mgmt BoardHelmut KraftCFO/Member-Mgmt Board
Axel MuellerChief Production & Dev Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil